The life science, healthcare, and food team at Cirio Advokatbyrå AB handles a full spectrum of mandates, from complex regulatory matters to disputes. In particular, the group is known for its work within digital health, alongside capital raisings in the life sciences sector. Practice head Per Hedman is well-regarded for his work in transactions, including cross-border M&A and venture capital investments, and has extensive experience in the pharma, medtech, and biotech sectors. Working alongside him is Hanna Tilus, who has expertise in intellectual property, regulatory, and technology law, and who also advises clients across pharma and health care.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘The individuals at Cirio are what truly set the firm apart. Per Hedman brings not only deep expertise but also a calm, solution-oriented mindset that makes even the most complex situations feel manageable. His ability to combine sharp legal insight with a pragmatic, business-focused approach has been invaluable.'
- ‘Cirio is a team that really stands out because of how quickly and effectively they work, without ever losing the personal touch. They combine top-level expertise with a genuine interest in their clients, which makes the whole experience feel collaborative and supportive.'
- ‘The individuals I have worked with at Cirio stand out for their accessibility, responsiveness, and deep sector knowledge. They are pragmatic, commercially minded, and consistently provide clear and solution-oriented advice. I particularly value their ability to understand complex challenges quickly and to communicate in a straightforward and collaborative manner, which distinguishes them from competitors.’
- ‘Cirio’s healthcare and life sciences team combines strong sector expertise with pragmatic and commercially relevant advice. They are collaborative, responsive, and solution-oriented, which makes them stand out compared to other firms. Their ability to navigate complex, multi-stakeholder matters and adapt flexibly to client needs is a key strength.’
- ‘I work mainly with Per Hedman. He cares about building and maintaining a long-term relationship in a way that makes it very easy to address complicated matters whenever they arise. He combines his own depth of expertise and that of his network with a great ability for pragmatic discussion and problem-solving. His associates are always on excellent terms as well.’
- ‘For me, they are the obvious choice for any topic that requires a deeper understanding of the life science industry. Whether it is deal terms, supply agreements, or IP, I feel confident they can handle it excellently. As their service is always excellent, I rely on them for much more.’
Key clients
- Takeda 10x Genomics Gesynta Pharma Elypta Boule Diagnostics Hadean Ventures Karolinska Development Intervacc Scandinavian Biopharma Sprint Bioscience Symcel Annexin Pharmaceutcials AlzeCure Pharma Anocca FrostPharma Industrifonden
Work highlights
Advised Alvotech on the listing of its shares on Nasdaq Stockholm and a SEK 750 million private placement.
Advised Gesynta Pharma on its SEK 347 million Series B round involving prominent investors, financing a Phase 2 clinical trial of vipoglanstat.
Advises Intervacc on life science legal matters and recently advised on a SEK 225 million guaranteed rights issue, completed in a challenging fundraising climate and requiring consideration of the Prospectus Regulation and the new Foreign Direct Investment Act.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
Per Hedman
Other key lawyers
Hanna Tilus; Jessica Grönberg